A new trading day began on Tuesday, with Heron Therapeutics Inc (NASDAQ: HRTX) stock price down -5.08% from the previous day of trading, before settling in for the closing price of $1.77. HRTX’s price has ranged from $1.04 to $3.93 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 0.21% over the last five years. Meanwhile, its annual earnings per share averaged 83.89%. With a float of $150.77 million, this company’s outstanding shares have now reached $151.70 million.
The firm has a total of 126 workers. Let’s measure their productivity. In terms of profitability, gross margin is 67.55%, operating margin of -17.61%, and the pretax margin is -19.0%.
Heron Therapeutics Inc (HRTX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Heron Therapeutics Inc is 0.87%, while institutional ownership is 75.77%.
Heron Therapeutics Inc (HRTX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 83.89% per share during the next fiscal year.
Heron Therapeutics Inc (NASDAQ: HRTX) Trading Performance Indicators
Here are Heron Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.74. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.18, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.06 in one year’s time.
Technical Analysis of Heron Therapeutics Inc (HRTX)
Analysing the last 5-days average volume posted by the [Heron Therapeutics Inc, HRTX], we can find that recorded value of 1.13 million was lower than the volume posted last year of 1.28 million. As of the previous 9 days, the stock’s Stochastic %D was 54.91%. Additionally, its Average True Range was 0.11.
During the past 100 days, Heron Therapeutics Inc’s (HRTX) raw stochastic average was set at 57.66%, which indicates a significant increase from 25.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.94% in the past 14 days, which was lower than the 97.28% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6610, while its 200-day Moving Average is $2.1925. Now, the first resistance to watch is $1.7700. This is followed by the second major resistance level at $1.8600. The third major resistance level sits at $1.9200. If the price goes on to break the first support level at $1.6200, it is likely to go to the next support level at $1.5600. Now, if the price goes above the second support level, the third support stands at $1.4700.
Heron Therapeutics Inc (NASDAQ: HRTX) Key Stats
With a market capitalization of 255.52 million, the company has a total of 152,095K Shares Outstanding. Currently, annual sales are 127,040 K while annual income is -110,560 K. The company’s previous quarter sales were 32,810 K while its latest quarter income was -4,850 K.
